T1	Participants 71 130	patients with advanced human immunodeficiency virus disease
T2	Participants 381 586	patients with human immunodeficiency virus (HIV) disease, absolute CD4 lymphocyte count of < 200/microL (or prior AIDS-defining opportunistic infection), and the presence of serum IgG to Toxoplasma gondii.
